antazoline is an approved drug
Compound class:
Synthetic organic
Comment: There is no information regarding approval for clinical use of this drug on the US FDA website. Other national approval agencies may have granted marketing authorisation.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes |
IUPAC Name |
N-benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)aniline |
International Nonproprietary Names | |
INN number | INN |
1142 | antazoline |
Database Links | |
CAS Registry No. | 91-75-8 |
ChEMBL Ligand | CHEMBL1305 |
DrugBank Ligand | DB08799 |
DrugCentral Ligand | 224 |
GtoPdb PubChem SID | 178103693 |
PubChem CID | 2200 |
Search Google for chemical match using the InChIKey | REYFJDPCWQRWAA-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | REYFJDPCWQRWAA |
Search PubMed clinical trials | antazoline |
Search PubMed titles | antazoline |
Search PubMed titles/abstracts | antazoline |
UniChem Compound Search for chemical match using the InChIKey | REYFJDPCWQRWAA-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | REYFJDPCWQRWAA-UHFFFAOYSA-N |
Wikipedia | Antazoline |